웰튼메디플렉스

비상장계속사업자

welltonmediplex Co.,Ltd.

송상호

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

웰튼메디플렉스

Business Reg. No. 1208118967 · CEO 송상호

I.Investment Overview

Target웰튼메디플렉스 (1208118967)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명웰튼메디플렉스
영문명welltonmediplex Co.,Ltd.
대표자송상호
사업자등록번호1208118967
법인등록번호1448110000602
설립일1991.06.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW5202155.5202267.1202367.5202467.32025
영업이익100M KRW2.2202114.4202220.2202319.9202419.32025
순이익100M KRW0.420210.820221.620232.920243.72025
Item20252024202320222021
자산총계616.4억원562.5억원400.9억원418.6억원440.3억원
부채총계437.2억원386.9억원394억원413.3억원435.9억원
자본총계179.3억원175.6억원6.9억원5.3억원4.5억원
매출액67.3억원67.5억원67.1억원55.5억원5억원
영업이익19.3억원19.9억원20.2억원14.4억원2.2억원
순이익3.7억원2.9억원1.6억원8,203만원4,040만원

VI.Financial Ratios

FY2025 basis

28.7%

영업이익률

5.5%

순이익률

0.6%

ROA

2.06%

ROE

243.88%

부채비율

29.08%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

웰튼메디플렉스 투심보고서 | Alpha Lenz